Abstract:The purification of a protein inhibiting lipid peroxidation led to the discovery of the selenoperoxidase GPx4 forty years ago. Thus, the evidence of the enzymatic activity was reached after identifying the biological effect and unambiguously defined the relationship between the biological function and the enzymatic activity. In the syllogism where GPx4 inhibits lipid peroxidation and its inhibition is lethal, cell death is operated by lipid peroxidation. Based on this rationale, this form of cell death emerged as regulated iron-enforced oxygen toxicity and was named ferroptosis in 2012. In the last decades, we learned that reduction of lipid hydroperoxides is indispensable and, in cooperation with prooxidant systems, controls the critical steady state of lipid peroxidation. This concept defined the GPx4 reaction as both the target for possible anti-cancer therapy and if insufficient, as cause of degenerative diseases. We know the reaction mechanism, but the details of the interaction at the membrane cytosol interface are still poorly defined. We know the gene structure, but the knowledge about expression control is still limited. The same holds true for post-transcriptional modifications. Reverse genetics indicate that GPx4 has a role in inflammation, immunity, and differentiation, but the observations emerging from these studies need a more specifically addressed biochemical evidence. Finally, the role of GPx4 in spermatogenesis disclosed an area unconnected to lipid peroxidation. In its mitochondrial and nuclear form, the peroxidase catalyzes the oxidation of protein thiols in two specific aspects of sperm maturation: stabilization of the mid-piece and chromatin compaction. Thus, although available evidence converges to the notion that GPx4 activity is vital due to the inhibition of lipid peroxidation, it is reasonable to foresee other unknown aspects of the GPx4 reaction to be disclosed.

Glutathione peroxidase 4 (Gpx4) and ferroptosis: what's so special about it?

GPX4, ferroptosis, and diseases

GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues

Recent Progress of Glutathione Peroxidase 4 Inhibitors in Cancer Therapy

Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases

System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy

Regulation of Ferroptotic Cancer Cell Death by GPX4

The Role of Glutathione Peroxidase 4 in Neuronal Ferroptosis and Its Therapeutic Potential in Ischemic and Hemorrhagic Stroke

GPX4 in cell death, autophagy, and disease

A white paper on Phospholipid Hydroperoxide Glutathione Peroxidase (GPx4) forty years later

Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis

Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges

ZX703: A Small-Molecule Degrader of GPX4 Inducing Ferroptosis in Human Cancer Cells

Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors.

Cysteine and homocysteine can be exploited by GPX4 in ferroptosis inhibition independent of GSH synthesis

Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling

Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis

Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment

Oxidative Metabolism as a Cause of Lipid Peroxidation in the Execution of Ferroptosis

Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis

BIOCHEMICAL MECHANISMS OF FERROPTOSIS